The graph represents a network of 3,658 Twitter users whose tweets in the requested range contained "ibm watson", or who were replied to or mentioned in those tweets. The network was obtained from the NodeXL Graph Server on Monday, 23 July 2018 at 10:31 UTC. The requested start date was Monday, 23 July 2018 at 00:01 UTC and the maximum number of days (going backward) was 14. The maximum number of tweets collected was 5,000. The tweets in the network were tweeted over the 11-day, 2-hour, 17-minute period from Wednesday, 11 July 2018 at 11:44 UTC to Sunday, 22 July 2018 at 14:01 UTC.

When new technology takes off, we sometimes assume the only early adopters are the young. While millennials are no doubt talking to the new wave of voice-activated speakers, it turns out that Google Home and Amazon Echo are really resonating with baby boomers. In fact, our research has found that boomers see their voice-activated speakers as more than a simple device. Here are three key things we discovered when researching boomers who own voice-activated speakers. Boomers are clearly using their devices for practical reasons.

IBM Watson Health will continue to collaborate with the U.S. Department of Veterans Affairs on the development of treatment regimens for veterans with cancer through next June. IBM Watson Health has announced an extension through June 2019 of its collaboration with the U.S. Department of Veterans Affairs (VA) to help treat veterans with cancer using artificial intelligence (AI). The partners use the Watson cognitive computing platform to inform the delivery of personalized treatment plans by the VA's oncologists. This requires researchers and clinicians to sequence patients' DNA to locate likely cancer-causing mutations and determine strategies to target those mutations. AI can help oncologists interpret genomic data faster and with less difficulty.

File photo - Attendees gather at an IBM Watson event in lower Manhattan, New York Jan. 9, 2014. Two years ago, oncologists with the US Department of Veterans Affairs started using IBM Watson artificial intelligence to identify targeted treatment options for cancer patients. Now, they will be able to continue that work for at least another year. The VA and IBM Watson Health today announced an extension of their partnership through at least June 2019. Working out of a precision oncology "hub" in Durham, N.C., a small group of VA oncologists and pathologists receive tumor samples from patients around the country.

IBM yesterday announced that several new European clients have selected IBM Watson Internet of Things (IoT) technologies. New contracts signed with Spanish electricity grid operator Red Eléctrica de España, Italian elderly care provider Cooperativa Sole, Dutch telecommunications operator Tele2 and Israeli manufacturer of smart air conditioning Electra Group are examples of IBM's commitment to transforming business and improving operations with the power of Artificial Intelligence (AI)-enabled, IBM Cloud-based Internet of Things (IoT) technologies. Red Eléctrica de España (http://www.ree.es/en), the sole transmission agent and operator of the national electricity system in Spain has selected IBM Watson IoT technologies as part of its Intelligent Asset Management initiative project. The electricity system operator's objective is to plan and optimize the maintenance and replacement activities of their strategic transmission assets (like substations and transmission lines) with the support of the IBM Watson IoT platform. With an IoT analytics solution that is designed specifically to help Energy and Utilities improve asset maintenance and utilization, a team from IBM Global Business Services (GBS) has begun implementation of the platform and is working in unison with REE to develop asset degradation models and design optimization plans specific to the electricity system operator's requirements.

BIG BLUE IBM has used its Watson artificial intelligence (AI) tech to develop a new algorithm for multi-face tracking. The system uses AI to track multiple individuals across scenes, despite changing camera angles, lighting, and appearances. Collaborating with Professor Ying Hung of the Department of Statistics and Biostatistics in Rutgers University, IBM Watson researcher Chung-Ching Lin led a team of scientists to develop the technology, using a method to spot different individuals in a video sequence. The system is also able to recognise if people leave and then re-enter the video, even if they look very different. To create this innovation in AI, Lin explained that the team first made'tracklets' for the people present in the source material.

IBM Watson Health and medical imaging contrast agent company Guerbet have entered a strategic partnership to develop artificial intelligence (AI) software to support liver cancer diagnostics and care by utilizing CT and MRI technology. The collaboration will have Guerbet and IBM Watson Health co-develop clinical decision support solutions including Watson Imaging Care Advisor for Liver, a diagnostic support tool that will utilize AI to automate the detection, staging, tracking, monitoring, therapy prediction and response of primary and second liver cancer for clinicians, according to a Guerbet press release published July 10. "Imaging is a critical area of healthcare where we believe artificial intelligence can be used to expand the physician's view so they can be more informed in their diagnostic and treatment decisions for their patients," said Anne Le Grand, vice president of imaging at IBM Watson Health.

Engineers recently laid off from IBM Watson Health, the division rooted in artificial intelligence, say the company's mission to make AI profitable is failing, according to IEEE Spectrum. IBM cut dozens of Watson Health employees--primarily from its three acquired companies Phytel, Explorys and Truven--at the end of May. The company is severely disorganized, which led to redundancies and internal competition, the former employees said. Now they are speaking out about IBM's issues with its AI. They allege the problems at Phytel stem from IBM's inability to make Watson profitable.

The CMO Performance Report 2018 report, from digital marketing challenger agency, QueryClick, surveyed over 150 Chief Marketing Officers for UK consumer brands with a revenue of over £150 million and an e-commerce offering, found that 66% of CMOs for large retail brands have plans to invest in machine learning to enhance their digital marketing strategies within the next 12 months. The survey also found that over half (53%) of retailers will invest in voice search technology within the next 12 months. By 2019, the voice recognition market is predicted[1] to be a $601 million industry, and its value is set to accelerate even further as research predicts[2] 50% of all searches will be voice searches by 2020. Overall, 75% of CMOs said their brand will change its SEO strategy to ensure it appears in voice-led search results. Of those, 43% said they would do this within the next 12 months.

IBM Watson burst onto the world stage in 2011 when it participated in the trivia-based game show Jeopardy!. The supercomputer beat out two former champions to claim a victory for "artificial intelligence". Since then, Watson has embarked on a number of challenges across a variety of domains, from identifying the best cancer treatments to improving weather forecasting. For its latest endeavor, Watson is looking to improve the quality of life for individuals with autism and other cognitive disorders. Autism refers to a group of complex disorders of brain development characterized by difficulties in social interaction, verbal and nonverbal communication and possible repetitive behaviors.